Wednesday, September 07, 2016 7:51:09 AM
BY MARTIN ALMANZA ON SEPTEMBER 7, 2016 BUSINESS
Click For Article
Geron Corporation’s (GERN) witnessed a gain of 9.82% in recent trading period with closing price of $ 3.02. The company’s last traded volume of 3.72 million shares was above it’s an average volume of 1.42 million shares.
In the trailing 12 months period, return on assets ratio of the Company was 0.80% and return on equity ratio was 0.90% while its return on investment ratio was -0.40%.
The stock as of last trading session moved 31.30% up from its 52 week low and was -43.02% behind its 52 week high.
The stock’s price switched up 11.15% 20-Days Simple Moving Average, added 12.28% from 50-Days Simple Moving Average and negatively -4.22% from 200 Days Simple Moving Average. The company has PEG ratio of 151.00 and price to cash ratio of 4.34.
In the profitability analysis, net profit margin of the firm was recorded at 3.40% and operating profit margin was calculated at 0.90% while Beta factor, which measures the riskiness of the security, was registered at 2.58.
EPS growth for this year is 100.10% and EPS growth for next year is expected to reach at 78.30%. EPS growth in past five years was 14.90% while EPS growth in next five years is projected to arrive at 5.00%. Sales growth past 5 years was measured at 59.10%.
The Company has 159.00 million shares outstanding and 158.33 million shares were floated in market. The short ratio in the company’s stock is documented at 19.79 and the short float is around of 17.76%. The average true range of the stock is observed at 0.10 and the relative strength index of the stock is recorded at 70.20.
Analyst recommendation for this stock stands at 2.20. The P/E ratio was recorded at 755.00.The volatility in the previous week has experienced by 4.69% and observed of 3.72% in the previous month.38.40% ownership is held by institutional investors while insiders hold ownership of 0.50%.
Liquidity ratio analysis:
In the liquidity ratio analysis; quick ratio for most recent quarter was 15.70 while current ratio for time period was 15.70. In most recent quarter, LT Debt/Equity ratio was listed at 0.00 and Total Debt/Equity ratio was noted at 0.00.
Performance history:
Looking about the past performance history, the company jumped 13.53% in past week and climbed 9.42% in one month. During the past three month period the stock surged 1.34% and increased 4.50% in past six month. During the twelve month it lost -9.31% and year to date performance of -37.60%.
Blessings to All
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.
Recent GERN News
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/19/2024 08:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 08:35:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 08:35:03 PM
- Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer • Business Wire • 09/09/2024 08:15:00 PM
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/22/2024 08:30:00 PM
- Geron Corporation Reports Second Quarter 2024 Financial Results and Business Highlights • Business Wire • 08/08/2024 11:00:00 AM
- Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS • Business Wire • 07/26/2024 11:30:00 AM
- Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024 • Business Wire • 07/23/2024 08:15:00 PM
- Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024 • Business Wire • 07/18/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 08:05:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2024 07:44:18 PM
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/20/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:05:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:05:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 09:53:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 04:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:03:44 PM
- Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia • Business Wire • 06/07/2024 01:58:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:05:20 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM